BEGIN:VCALENDAR
PRODID:-//github.com/ical-org/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:STANDARD
DTSTART:20241103T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:EST
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250309T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:EDT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:This talk will introduce Moderna’s RSV vaccine program and dis
 cuss an epidemiologist’s role in the clinical development of an RSV vacci
 ne from Phase 1 through the post-marketing period. Focuses will include k
 ey leadership and supporting roles played during Phase 3 vaccine efficacy
  trials as well as the roles played in market shaping and product differe
 ntiation activities.\n\nSpeaker:\nCathy Panozzo\, PhD\, MPH\n\nAdmission:
 \nFree\n\nDetails URL:\nhttps://medicine.yale.edu/event/ysph-emd-seminar-
 10/\n
DTEND;TZID=America/New_York:20221102T130000
DTSTAMP:20261009T154640Z
DTSTART;TZID=America/New_York:20221102T120000
GEO:41.302961;-72.931638
LOCATION:106A\, 47 College Street\, New Haven\, CT\, United States
SEQUENCE:0
STATUS:Confirmed
SUMMARY:YSPH EMD Seminar: “How does epidemiology support clinical developm
 ent of vaccines? The example of Moderna’s RSV vaccine program in older ad
 ults”
UID:8bda5b5c-0d4a-4547-80ee-ad50ec3a1d99
END:VEVENT
END:VCALENDAR